Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a medical technology company that designs, manufactures, and markets orthopedic reconstructive products. Its main offerings include knee and hip implants, as well as sports medicine, biologics, foot and ankle, upper extremities, trauma, and craniomaxillofacial (CMFT) products. The company also provides surgical products, bone cement, and a suite of digital and robotic technologies, such as the ROSA Robot, which assists surgeons in total or partial knee arthroplasty. Additionally, the ZBEdge Platform connects robotic and digital tools to collect data before, during, and after surgery, delivering insights to improve surgical outcomes. These products and solutions are used to treat patients with bone, joint, or soft tissue injuries and disorders.

Zimmer Biomet Holdings, Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol ZBH. The company's financials are reported in US Dollars (USD), as it is headquartered in the United States. Being listed on the NYSE provides investors with access to one of the world's largest and most liquid stock exchanges, and the use of USD as the reporting currency aligns with its primary market and operational base in the US.

Zimmer Biomet operates in the Healthcare sector, specifically within the Medical Devices industry. As a medical technology company, it focuses on developing and manufacturing products that help treat musculoskeletal conditions, including joint replacements, sports medicine repairs, and trauma fixation. The Medical Devices industry encompasses a wide range of products used in surgical procedures, diagnostics, and patient care, and Zimmer Biomet is a key player in the orthopedic segment of this industry.

Zimmer Biomet serves a diverse customer base that includes orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and specialists. The company also works with agents, healthcare purchasing organizations, and buying groups. Its products are used in surgical procedures to treat patients with bone, joint, or soft tissue injuries and disorders. By targeting both individual surgeons and large healthcare organizations, Zimmer Biomet ensures its medical devices and technologies reach a broad spectrum of end-users across various healthcare settings.

Zimmer Biomet offers a range of notable products and technologies. Its orthopedic reconstructive portfolio includes knee and hip implants. The company also provides sports medicine products for repairing soft tissue injuries in the knee and shoulder, as well as craniomaxillofacial and thoracic products for face and skull reconstruction and chest bone stabilization after heart surgery or trauma. A key technology is the ROSA Robot, which assists surgeons with implant positioning in total or partial knee arthroplasty. Additionally, the ZBEdge Platform integrates robotic and digital technologies to collect data before, during, and after surgery, delivering insights to help surgeons make informed decisions. These innovations highlight the company's focus on combining medical devices with digital solutions.